BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 15254847)

  • 1. The reliability and validity of the Oppositional Defiant Behavior Inventory.
    Harada Y; Saitoh K; Iida J; Sakuma A; Iwasaka H; Imai J; Hirabayashi M; Yamada S; Hirabayashi S; Uchiyama T; Ohta S; Amano N
    Eur Child Adolesc Psychiatry; 2004 Jun; 13(3):185-90. PubMed ID: 15254847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does oppositional defiant disorder have temperament and psychopathological profiles independent of attention deficit/hyperactivity disorder?
    Kim HW; Cho SC; Kim BN; Kim JW; Shin MS; Yeo JY
    Compr Psychiatry; 2010; 51(4):412-8. PubMed ID: 20579516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A;
    Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADHD subtypes and co-occurring anxiety, depression, and oppositional-defiant disorder: differences in Gordon diagnostic system and Wechsler working memory and processing speed index scores.
    Mayes SD; Calhoun SL; Chase GA; Mink DM; Stagg RE
    J Atten Disord; 2009 May; 12(6):540-50. PubMed ID: 18664713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Validity and reliability of the Turkish version of the Wender Utah Rating Scale for attention-deficit/hyperactivity disorder in adults].
    Oncü B; Olmez S; Sentürk V
    Turk Psikiyatri Derg; 2005; 16(4):252-9. PubMed ID: 16362844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Kiddie-SADS allows a dimensional assessment of externalizing symptoms in ADHD children and adolescents.
    Jans T; Weyers P; Schneider M; Hohage A; Werner M; Pauli P; Warnke A
    Atten Defic Hyperact Disord; 2009 Dec; 1(2):215-22. PubMed ID: 21432584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multitrait (ADHD-IN, ADHD-HI, ODD toward adults, academic and social competence) by multisource (mothers and fathers) evaluation of the invariance and convergent/discriminant validity of the Child and Adolescent Disruptive Behavior Inventory with Thai adolescents.
    Burns GL; Desmul C; Walsh JA; Silpakit C; Ussahawanitchakit P
    Psychol Assess; 2009 Dec; 21(4):635-41. PubMed ID: 19947797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of the development of depressive mood and oppositional defiant behavior among boys with attention deficit hyperactivity disorder: differences between subtypes.
    Ushijima H; Usami M; Saito K; Kodaira M; Ikeda M
    Psychiatry Clin Neurosci; 2012 Jun; 66(4):285-91. PubMed ID: 22624733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is oppositional defiant disorder a meaningful diagnosis in adults? Results from a large sample of adults with ADHD.
    Harpold T; Biederman J; Gignac M; Hammerness P; Surman C; Potter A; Mick E
    J Nerv Ment Dis; 2007 Jul; 195(7):601-5. PubMed ID: 17632251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Problem of item overlap between the psychopathy screening device and attention deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder rating scales.
    Burns GL
    Psychol Assess; 2000 Dec; 12(4):447-50. PubMed ID: 11147115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Validation of the Turkish versions of the short-form Conners' teacher and parent rating scales].
    Dereboy C; Senol S; Sener S; Dereboy F
    Turk Psikiyatri Derg; 2007; 18(1):48-58. PubMed ID: 17364268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for DSM-IV externalizing disorders with the Child Behavior Checklist: a receiver-operating characteristic analysis.
    Hudziak JJ; Copeland W; Stanger C; Wadsworth M
    J Child Psychol Psychiatry; 2004 Oct; 45(7):1299-307. PubMed ID: 15335349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Family functioning and psychosocial characteristics in children with attention deficit hyperactivity disorder with comorbid oppositional defiant disorder or conduct disorder].
    Kiliç BG; Sener S
    Turk Psikiyatri Derg; 2005; 16(1):21-8. PubMed ID: 15793695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oppositional defiant disorder with onset in preschool years: longitudinal stability and pathways to other disorders.
    Lavigne JV; Cicchetti C; Gibbons RD; Binns HJ; Larsen L; DeVito C
    J Am Acad Child Adolesc Psychiatry; 2001 Dec; 40(12):1393-400. PubMed ID: 11765284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should sex-specific norms be used to assess attention-deficit/hyperactivity disorder or oppositional defiant disorder?
    Waschbusch DA; King S
    J Consult Clin Psychol; 2006 Feb; 74(1):179-85. PubMed ID: 16551155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CBCL clinical scales discriminate ADHD youth with structured-interview derived diagnosis of oppositional defiant disorder (ODD).
    Biederman J; Ball SW; Monuteaux MC; Kaiser R; Faraone SV
    J Atten Disord; 2008 Jul; 12(1):76-82. PubMed ID: 17494835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatric disorders and behavioral problems in children and adolescents with Tourette syndrome.
    Ghanizadeh A; Mosallaei S
    Brain Dev; 2009 Jan; 31(1):15-9. PubMed ID: 18558469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric comorbidity associated with DSM-IV ADHD in a nonreferred sample of twins.
    Willcutt EG; Pennington BF; Chhabildas NA; Friedman MC; Alexander J
    J Am Acad Child Adolesc Psychiatry; 1999 Nov; 38(11):1355-62. PubMed ID: 10560221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder.
    Bangs ME; Hazell P; Danckaerts M; Hoare P; Coghill DR; Wehmeier PM; Williams DW; Moore RJ; Levine L;
    Pediatrics; 2008 Feb; 121(2):e314-20. PubMed ID: 18245404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.